|
Unlock ST Premium FREE Trial: Discover top stock picks & smart tools
|
|
|
Good morning!
Stock futures rose on Monday ahead of key central bank decisions, with S&P 500 futures up 0.35%, Dow futures gaining 253 points (0.48%), and Nasdaq-100 futures advancing 0.36%.
The Federal Reserve, European Central Bank, and Bank of Japan will announce policy decisions Wednesday, Thursday, and Friday, respectively.
Oil prices eased, with Brent crude falling 2.20% to $114.52 per barrel and WTI declining 2.24% to $101.03.
Fridayβs sell-off pushed the Dow down over 650 points, while the S&P 500 fell 0.5%. Markets expect a 90% chance the Fed holds rates at 3.75%β4%.
|
|
|
Find undervalued stocks with positive ratings
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
Record-High Copper Ignites District-Scale Discovery Below $2
Copper has blasted to all-time highs as AI data centers, electrification, and grid expansion drive demand for the strategic metal. One small-cap Canadian copper company trading below $2 is unlocking a historic Yukon copper belt that was never explored as a unified system. High-grade copper is already confirmed at the flagship, multiple opportunities are advancing across the belt, and drilling is accelerating with multiple rigs turning.
See what the drills are targeting next β before the next copper-gold results hit.
|
|
|
π PRE-MARKET MOVERS TOP GAINERS BEFORE THE BELL
SciSparc Ltd (SPRC)
+45.87%
stock soared to $1.59 in pre-market trading after filing a Form 6-K with the SEC.
Xencor Inc (NASDAQ: XNCR)
+27.84%
shares are trading up at $32.19 at the time of writing after announcing updated results from the Phase 1 study of XmAb819, an ENPP3 x CD3 T-cell engaging bispecific antibody, in patients with advanced clear cell renal cell carcinoma (ccRCC).
Treasure Global Inc (TGL)
+34.27%
rose to $0.29 in pre-market trading today after filing an 8-K with the SEC.
ArriVent BioPharma Inc (AVBP)
+10.95%
jumped to $23.30 in pre-market trading Monday after announcing initial encouraging Phase 1 results for ARR-217, (MRG007), a cadherin-17 (CDH17)-targeting antibody-drug conjugate (ADC) developed in partnership with Lepu Biopharma Co., Ltd., in patients with gastrointestinal malignancies.
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
Undiscovered Sub β $1 Gold-Silver Royalty Stock Takes Flight
Gold and silver are in a powerful bull market β and one little-known sub β $1 royalty stock is entering its biggest growth phase yet. The company is already generating record revenue from producing gold and silver mines and has just announced the largest transaction in its history. Better still, a powerful strategic relationship provides direct access to a steady pipeline of deals across the global mining landscape. And the smart money is already paying attention.
Get in early while shares are still below $1.
|
|
|
π£ ANALYST UPGRADES & DOWNGRADES FRESH WALL STREET CALLS
BofA Securities turned bullish on Allegion PLC (ALLE)
BUY,
upgrading the stock and assigning a $200 price target, representing potential upside of 11.74% from Sunday's close.
Pharvaris NV (PHVS)
has won the favor of BofA Securities' equity research team. The firm upgraded the shares from Neutral to
BUY
and moved its price target to $44, suggesting 40.08% additional upside for the stock.
Valley National Bancorp (VLY)
received an upgrade from analysts at Keefe Bruyette, who also set their one-year price target on the stock to $17. They changed their rating on VLY to
OUTPERFORM
from Mkt Perform in a recently issued research note.
Raymond James reduced its rating on First Industrial Realty Trust Inc (FR)
stock to OUTPERFORM
from Strong Buy and assigned the price target to $71.
Piper Sandler analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Globe Life Inc (GL)
has been changed to NEUTRAL
from Overweight and the new price target is set at $165.
Analysts at Stephens downgraded Illumina Inc (ILMN)
stock to EQUAL-WEIGHT
from Overweight, and the new price target is set at $275.
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
5 Stocks to Buy for Q4 2026
This year has thrown the market a war with Iran, $100 oil and the Fed's first rate hike since 2023. Stocks climbed anyway. This free report reveals 5 companies with the earnings and catalysts to finish 2026 strong. See which ones made our list.
Click here for your free report
|
|
|
π LATEST INSIDER ACTIVITY EXECUTIVE BUYS & SELLS
American Tower Corp (AMT)
BUY
β Director, Clarke Teresa Hillary declared the purchase of shares taking place on Oct 20 '26 at $183.2 for some 43 shares. The transaction amount was around $7,864.
Nebius Group NV (NBIS)
BUY
β Director, Grimme Arne bought on Oct 21 '26 a total of 148 shares at $167.94 on average. The purchase cost the insider an estimated $24,855.
Natera Inc (NTRA)
SELL
β CO-FOUNDER, Sheena Jonathan announced the sale of shares taking place on Oct 21 '26 at $410.55 for some 3150 shares. The total came to more than $1.29 million.
Crowdstrike Holdings Inc (CRWD)
SELL
β PRESIDENT AND CEO, Kurtz George sold on Oct 22 '26 a total 10000 shares at $238.88 on average. The insiderβs sale generated proceeds of almost $2.39 million.
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
1 trade idea. 1 email. Every day.
Trusted by over 130,000 people, this free daily newsletter provides self-directed investors with tomorrow's trade idea, today sourced from top wall street analysts.
Subscribe today for free
|
|
|
```html
π EARNINGS TO WATCH TODAY
Top US earnings releases scheduled for today include Welltower Inc (WELL). It will announce its September 2026 financial results. The company is expected to report earnings of $0.71 per share from revenues of $3.75B in the three-month period.
Analysts expect Cadence Design Systems Inc (CDNS) to report a net income (adjusted) of $2.05 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended September 2026 is predicted to come in at $1.62B.
Nucor Corp (NUE), due to announce earnings after the market closes today, is expected to report earnings of $5.83 per share on revenues of $10.79B for the recently concluded three-month period.
``` |
|
|
That's it for today. Thanks for reading. Good luck out there!
Best Regards,
Stocks Telegraph Team
|
|
|
Unlock Full Market Intelligence
Get unlimited screener access, real-time analyst ratings, insider alerts, and exclusive stock breakdowns β all in one premium subscription.
Best value on the yearly plan Β· Cancel anytime
|
|
|
Disclaimer:
Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.
|
|
|
β